Retainer Agreement
info@rosenlegal.com

Regulus Therapeutics shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Regulus Therapeutics Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Regulus Therapeutics Inc. (NASDAQ: RGLS) resulting from allegations that Regulus Therapeutics may have issued materially misleading business information to the investing public.

If you purchased shares of Regulus Therapeutics on or before June 27, 2016 and would like to join the action, please click "Join This Class Action" above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Regulus Therapeutics Inc. – RGLS

New York, N.Y., June 28, 2016.  Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Regulus Therapeutics Inc. (NASDAQ: RGLS) resulting from allegations that Regulus Therapeutics may have issued materially misleading business information to the investing public.

On June 27, 2016, Regulus Therapeutics announced during aftermarket hours that it received verbal notice from the U.S. Food and Drug Administration (“FDA”) that the FDA had placed the Regulus Therapeutics’ investigational new drug for the treatment of chronic hepatitis C virus infection on clinical hold after a second serious adverse event of jaundice was reported. On this news, shares of Regulus Therapeutics sharply during intraday trading on June 28, 2016. 

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Regulus Therapeutics investors. If you purchased shares of Regulus Therapeutics on or before June 27, 2016, please visit the website at http://rosenlegal.com/cases-916.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com